http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100266500-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ab8d5e4558668a6dd1124fec4302976
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-02
filingDate 1999-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee22edeb0371851cca8f4ffb7d4d9c09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8a3f46dda0b61a2a04d30cf2492466a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2206bae6b3c05dd9607dc054a606f34d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce7abe608543c5cab940c7d4ea454e08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51bcba107e7d6680c34e61749481d922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1375c2c2ccdc2b4b0ea5fd7813130060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c823c6392a6341b49ac566f55b36e7f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21751d984933b7a43653186fd5f7a495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1d3718765f51d885315078ade1e082b
publicationDate 2000-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100266500-B1
titleOfInvention Novel oxazolidine derivatives and process for preparing the same
abstract PURPOSE: Provided is a manufacturing method of paclitaxel of the formula (1). Further, novel intermediates used for manufacturing paclitaxel and their manufacturing methods are provided. CONSTITUTION: Paclitaxel is represented by the formula (1) wherein, Ph is phenyl, Ac is acetyl, and Bz is benzoyl. The intermediate used for manufacturing paclitaxel is provided by reacting a novel oxazoline derivative of the formula (2a) or its salt, and (2R,3S)-phenylisoserine derivative of the formula (10) with a compound of the formula (11), in the solvent, in the presence of acid catalyst. In the formulae, X is halogen; R is hydrogen or C1-C3 of alkyl; and R5, R6, and R7 represent individually C1-C4 of alkyl or phenylalkyl, or R5 and R6 form 4-7 membered ring of cyclic chain together.
priorityDate 1997-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457630265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823

Total number of triples: 29.